Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)
Clinical trial NCT04353180 · UNKNOWN
Trial details
- NCT number
- NCT04353180
- Sponsor
- Kafrelsheikh University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2021-10-01
- Enrollment
- 100000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.